Doxylamine succinate and pyridoxine hydrochloride
These highlights do not include all the information needed to use DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE DELAYED-RELEASE TABLETS. delayed-release tablets, for oral use. Initial U.S. Approval: 1976
3670d66e-c1e4-42ce-8760-c3d5accad925
HUMAN PRESCRIPTION DRUG LABEL
Oct 24, 2023
Actavis Pharma, Inc.
DUNS: 119723554
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Doxylamine succinate and pyridoxine hydrochloride
Product Details
FDA regulatory identification and product classification information